This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Raisio plc
5/13/2025
Tervetuloa seuraamaan Raisioon ensimmäisen vuosi neljännekseen tuloskatsausta. Mun nimi on Pasi Flitman ja olen toimitusjohtajana Raisiolla ja mukana talousjohtajamme Mika Saarinen. Tervehdys. Vuosi on lähtenyt Raisioon kannalta hyvin alkuun ja saatu hyvä alku uuteen strategiakauteen. Ensimmäisellä vuosi neljänneksellä the market is clearly faster in terms of turnover growth, about 4%, which was 4%, where our main targets were our health, food, and business activities. Also, the revenue development was quite good. The positive development came from a wide range of fields. our main markets from Great Britain and England and from all the most important categories and brands. We have not been dependent on any individual market. In Finland, especially, the 100-year celebration activities of the brand Elovena made Elovena a very good 7% increase and similarly in Great Britain Benegol continued to grow with a growth rate of up to 7%, and in Finland, Benegol's growth was up to 10%. At the same time, in terms of business-to-business, the development was a bit of a double-edged sword. The market prices of Bilja were falling, and high-price competition, weight profitability in traditional industrial sales, but at the same time, the export market It went really well in the gluten-free diet and in the sale of vegetable analgesics, a lot of activities were postponed to the first quarter, and there is a positive impact on us in the first quarter of the year.
Yes, and then here on my side a few numbers from a different perspective. according to the article, the income of the invested capital has also improved due to this income improvement and is now more than 10% it is also a very good start for this recognition period and for the development of this strategy phase that has now started and at the same time the view is attached to the previously improved net income debt, which is already minus 80 million, so one of us of course the goals of the strategy period are also to grow inorganic, smartly and also inorganic, and that means that we have quite good opportunities to put it in balance and ensure it from the point of view of use. Our cash flow has been quite good for several years, and even now, in the future, it will mainly be fed by improved income, improved consumption, but in the last couple of years, we have achieved a significantly smaller and lower level of our consumer goods. They are about 13-12% of our turnover at the moment, and it is quite good in terms of level, according to some of our goals, i.e. in terms of reducing consumer goods, there is no significant increase in the flow of money expected this year, but of course it will stay at a good level depending on the result. from this page, and then I will also repeat these views that have been published during the decision-making information, where we confirm this year's improved growth in the turnover rate and here in the statement we also pay shares in the spring 14 cm in total, of which this part was an additional component, so this component will remain even compared to the last few years, and there will also be gains this season, so the goals are somewhere ahead, i.e. our policy, the component policy is between 50 and 100 percent of the net income related to EPSI, and that is the line and possibility that after a year or two, the companies will decide in a good way.
A little more specifically about health and food. So here was the question of our brand products for consumers, consumer and business operations. The most important market areas are Finland, Great Britain, Ireland, Poland, Belgium and Ukraine. All business areas have developed positively in terms of business exchange. As I said earlier, the development has been wide, it has not been dependent on individual markets or individual categories or brands. In this business area, business exchange has increased by 38%. The market for everyday goods has been quite stable compared to last year. So, clearly, the market is growing faster according to our goals. Comparatively, the turnover has increased by almost 17%. In this good development, the key brands, namely Penecol and Eloveen, have had the ability to renew and expand into new categories. The turnover has also developed particularly well, especially in Western Europe and Northern Europe, Eastern and Central Europe, and the turnover remains at the level of the comparison period. In terms of the expansion of the field, I would like to tell you that we have opened new markets this year with Elovena in March. in Denmark and in Spain after the end of the quarter. The way to expand to new markets has been improved, and we are starting to develop these new expansion models, which are based on a lot of cooperation partners, distributors and other cooperation partners, with which we can get to several new markets faster. also at a lower cost and at a lower risk level. Then, in terms of health ingredients, the development has been slightly diversified. Here we have these vegetable-based food items and ingredients that are sold to industries and large restaurants, and then boat licenses, and then, in fact, this is quite a global business. The main focus is in Europe. This is a bit of a double-edged sword in the sense that traditional industrial sales have been a bit more challenging. The sales value of domestic industry has dropped by about 20%, but on the contrary, the sales growth of gluten-free dairy products has increased by about 30%, which brought about a change in the 1.3% growth in the fourth year. The result, on the other hand, has developed very positively. There, indeed, in the background development, the development of this sales mix, clearly more profitable products, also more profitable customers have been able to be prioritized, and then in the sale of vegetable ester, this continuation helped to support this in the fourth year.
Yes, and a couple of weeks later, if I'm not mistaken, RAISE is also hosting a capital market day, it is held in Helsinki and the registration links for institutional investors, analysts and the media can be found on our website and on the other hand, through this webcast, anyone can can follow the same example and hopefully you will follow as well, we have a four-year break from the last market day and market and company and views and strategy, everything has changed quite a bit after that, so hopefully interesting interesting to tell, now for example during the first four years we started our vegetable protein business where there is also a certain kind of new uusi murroskohta ja uusi alku sitten ilman sitä, niin tässä on monenlaista sitten kerrottavaa. Toivomme olevan kiinnostavia.
Samalla päästään kertomaan tosiaan paitsi syveltämään meidän strategiaa, niin myöskin meidän uutta organisaatiomallia, josta silloin tiedämme, että pystymme kertomaan enemmän. Tässä kohtaa meillä, en voinut tarkistaa, että oliko meillä kysymyksiä tai tullut tuonne It doesn't look like there are any questions. I will present them at this point, if there are any. It doesn't look like there are any. A big thank you to everyone who has followed and been with us, and a wonderful rest of the spring to you as well. Thank you.